In the latest issue of Official Journal published yesterday, an official decree (No. 428 of the year 2025) was published, terminating the functions of Chokri Hammouda at the head of the Central Pharmacy of Tunisia.
This decision marks the end of his mandate as director of the public establishment, responsible for the management and supply of medicines for the country.
The same day, a new decree (No. 429 of the year 2025) dated October 8, 2025, formalized the appointment of Amel Fattoum to the position of President and CEO of the Central Pharmacy.
This appointment comes in a context where the establishment plays a strategic role in regulating the Tunisian pharmaceutical market and securing the supply of essential medicines for the population.
The Central Pharmacy of Tunisia, founded to centralize the purchase and distribution of medicines in the country, regularly faces challenges linked to shortages, logistics and the modernization of its infrastructure.
The appointment of Amel Fattoum is seen as a key step to strengthen governance and improve the efficiency of the institution.
